Mudar Dalloul

ORCID: 0000-0003-3538-086X · 10 papers in corpus
2017
General pain, pelvic regional pain, gastrointestional and affective symptoms are common among women with endometriosis-related pain and may affect study retention during clinical trials
·doi:10.1016/j.fertnstert.2017.07.143
2015
Effect of lupron vs norethindrone treatment on lipid profile of women with symptomatic endometriosis
·doi:10.1016/j.fertnstert.2015.07.499
2015
Improvement in endometriosis-related pelvic pain with leuprolide or norethindrone treatment
·doi:10.1016/j.fertnstert.2015.07.507
2014
Health-related quality of life improvement in women with endometriosis-associated pain during treatment
·doi:10.1016/j.fertnstert.2014.07.055
2013
Changes in bone density in women with endometriosis on leuprolide vs norethindrone treatment
·doi:10.1016/j.fertnstert.2013.07.1700
2012
Changes in self-reported symptoms of women with endometriosis during treatment
·doi:10.1016/j.fertnstert.2012.07.777
2011
Urinary Cortisol Metablism in Women with Endometriosis
·doi:10.1210/endo-meetings.2011.part3.p26.p3-200
2010
Changes in quality of life (QOL) in women with symptomatic endometriosis by pain type during treatment
·doi:10.1016/j.fertnstert.2010.07.797
2010
Prevalence of metabolic syndrome and changes in lipid profile of women with endometriosis during treatment
·doi:10.1016/j.fertnstert.2010.07.799
2008
Serum F11R/JAM-a levels in women with symptomatic endometriosis
·doi:10.1016/j.fertnstert.2008.07.247